Antiviral chemotherapy.
Over the last few years, several new antiviral agents have been added to the chemotherapeutic armamentarium. This review discusses advances in the treatment of HIV disease in children and adults. More pronounced antiviral effects have been achieved through the study of new agents such as the protease inhibitors as well as through a better understanding of previously approved drugs, such as reverse transcriptase inhibitors.
Mueller
B U
BU
Children's Hospital, Department of Medicine, Boston, MA 02115, USA.
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D019829:Nevirapine; D011480:Protease Inhibitors / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D019438:Ritonavir / Q000627:therapeutic use; D019258:Saquinavir / Q000627:therapeutic use; D018119:Stavudine / Q000627:therapeutic use
D000998:Antiviral Agents; D011480:Protease Inhibitors; D011725:Pyridines; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D019469:Indinavir; D019829:Nevirapine; D018119:Stavudine; D019258:Saquinavir; D019438:Ritonavir